³í¹®) MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇ»ý¸í½Ã½ºÅÛÁ¤º¸Çб³½Ç ºóÁøÇõ ±³¼ö(»çÁø)